Search Results
Search for other papers by Andrea Weckman in
Google Scholar
PubMed
Search for other papers by Fabio Rotondo in
Google Scholar
PubMed
Search for other papers by Antonio Di Ieva in
Google Scholar
PubMed
Search for other papers by Luis V Syro in
Google Scholar
PubMed
Search for other papers by Henriett Butz in
Google Scholar
PubMed
Search for other papers by Michael D Cusimano in
Google Scholar
PubMed
Search for other papers by Kalman Kovacs in
Google Scholar
PubMed
neoplasia, endocrine tumors occur more rarely ( Table 1 ). Endocrine tumors are defined as neoplasia of the hormone-secreting cells of the classic endocrine glands, including the pituitary, thyroid, parathyroid and adrenal glands, as well as the ovaries and
Search for other papers by Tomoko Sekiya in
Google Scholar
PubMed
Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed
Search for other papers by Katiuscia Benfini in
Google Scholar
PubMed
Search for other papers by Viviane C Longuini in
Google Scholar
PubMed
Search for other papers by Raquel S Jallad in
Google Scholar
PubMed
Search for other papers by Marcio C Machado in
Google Scholar
PubMed
Search for other papers by Tatiana D Goncalves in
Google Scholar
PubMed
Search for other papers by Luciana H Osaki in
Google Scholar
PubMed
Search for other papers by Leonardo Higashi in
Google Scholar
PubMed
Endocrine Genetics Unit LIM-25, Neuroendocrinology Unit, Adrenal Unit (LIM-42), Experimental Oncology Laboratory (LIM-24), Nursing School, School of Public Health, Endocrinology Division, Brigadeiro Hospital, Federal University of Sao Paulo, Human Genome Research Center, Department of Cell and Developmental Biology, Instituto do Cérebro, National Institute of Aging, Institute of Pathology, School of Medicine, Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil
Search for other papers by Jose Viana-Jr in
Google Scholar
PubMed
Search for other papers by Claudio Kater in
Google Scholar
PubMed
Search for other papers by Misu Lee in
Google Scholar
PubMed
Search for other papers by Sara Molatore in
Google Scholar
PubMed
Search for other papers by Guilherme Francisco in
Google Scholar
PubMed
Search for other papers by Roger Chammas in
Google Scholar
PubMed
Search for other papers by Michel S Naslavsky in
Google Scholar
PubMed
Endocrine Genetics Unit LIM-25, Neuroendocrinology Unit, Adrenal Unit (LIM-42), Experimental Oncology Laboratory (LIM-24), Nursing School, School of Public Health, Endocrinology Division, Brigadeiro Hospital, Federal University of Sao Paulo, Human Genome Research Center, Department of Cell and Developmental Biology, Instituto do Cérebro, National Institute of Aging, Institute of Pathology, School of Medicine, Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil
Search for other papers by David Schlesinger in
Google Scholar
PubMed
Search for other papers by Patricia Gama in
Google Scholar
PubMed
Search for other papers by Yeda A O Duarte in
Google Scholar
PubMed
Search for other papers by Maria Lucia Lebrão in
Google Scholar
PubMed
Search for other papers by Mayana Zatz in
Google Scholar
PubMed
Search for other papers by Osorio Meirelles in
Google Scholar
PubMed
Search for other papers by Bernardo Liberman in
Google Scholar
PubMed
Search for other papers by Maria Candida B V Fragoso in
Google Scholar
PubMed
Search for other papers by Sergio P A Toledo in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Introduction In the last two decades, genetic studies of endocrine tumor syndromes have identified a number of susceptibility genes including several tumor suppressors (multiple endocrine neoplasia type 1 ( MEN1 ), VHL , NF1 , SDHA , SDHB
Search for other papers by Michael Solarski in
Google Scholar
PubMed
Search for other papers by Fabio Rotondo in
Google Scholar
PubMed
Lady Davis Institute, Jewish General Hospital and Research Institute, McGill University Health Centre, Montreal, Quebec, Canada
Search for other papers by William D Foulkes in
Google Scholar
PubMed
Search for other papers by John R Priest in
Google Scholar
PubMed
Search for other papers by Luis V Syro in
Google Scholar
PubMed
Search for other papers by Henriett Butz in
Google Scholar
PubMed
Search for other papers by Michael D Cusimano in
Google Scholar
PubMed
Search for other papers by Kalman Kovacs in
Google Scholar
PubMed
well ( Fig. 1 ). Figure 1 Schematic diagram of the various locations of endocrine tumors associated with DICER1 syndrome. A full colour version of this figure is available at https://doi.org/10.1530/ERC-17-0509 . DICER1 is located on
Search for other papers by A Perren in
Google Scholar
PubMed
Search for other papers by S Schmid in
Google Scholar
PubMed
Search for other papers by T Locher in
Google Scholar
PubMed
Search for other papers by P Saremaslani in
Google Scholar
PubMed
Search for other papers by C Bonvin in
Google Scholar
PubMed
Search for other papers by P U Heitz in
Google Scholar
PubMed
Search for other papers by P Komminoth in
Google Scholar
PubMed
endocrine tumors have been conducted (with the exception of thyroid tumors), although there are several indications pointing towards a possible role of BRAF in this type of tumor also. First, like melanomas ( Dupin & Le Douarin 2003 ), a subset of endocrine
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
Search for other papers by Joseph Rubin in
Google Scholar
PubMed
Search for other papers by Michael B Farnell in
Google Scholar
PubMed
Search for other papers by Clive S Grant in
Google Scholar
PubMed
Search for other papers by Gloria M Petersen in
Google Scholar
PubMed
Introduction Pancreatic endocrine tumors (PETs) are uncommon neoplasms with an incidence of <1 per 100 000 person-years in population studies ( Moldow & Connelly 1968 , Buchanan et al . 1986 , Eriksson et al . 1989 , Watson et al . 1989
Search for other papers by D Campana in
Google Scholar
PubMed
Search for other papers by F Nori in
Google Scholar
PubMed
Search for other papers by R Pezzilli in
Google Scholar
PubMed
Search for other papers by L Piscitelli in
Google Scholar
PubMed
Search for other papers by D Santini in
Google Scholar
PubMed
Search for other papers by E Brocchi in
Google Scholar
PubMed
Search for other papers by R Corinaldesi in
Google Scholar
PubMed
Search for other papers by P Tomassetti in
Google Scholar
PubMed
exerts a trophic effect on ECL-cells, which leads to hyperplasia and, in some cases, to gastric endocrine tumors ( Waldum et al . 1998 , Lehy et al . 2000 ). In particular, type I tumors occur mostly in women and are rarely symptomatic ( Borch et al
Search for other papers by Thomas J Giordano in
Google Scholar
PubMed
more common cancers, endocrine tumors sometimes do not attract equal attention and resources largely due to their relative rare nature. Fortunately for these patients, many endocrine cancer types have been investigated as part this genomic revolution
Search for other papers by Cuiqi Zhou in
Google Scholar
PubMed
Search for other papers by Yunguang Tong in
Google Scholar
PubMed
Search for other papers by Kolja Wawrowsky in
Google Scholar
PubMed
Search for other papers by Serguei Bannykh in
Google Scholar
PubMed
Search for other papers by Ines Donangelo in
Google Scholar
PubMed
Search for other papers by Shlomo Melmed in
Google Scholar
PubMed
-time PCR (A and B); Oct-1 and hPTTG1 protein levels were measured by western blot (C and D). Oct-1 and hPTTG1 are concordantly expressed in endocrine tumors and colon cancers hPTTG1 is overexpressed in multiple human tumors including pituitary, breast, and
Search for other papers by Francesco Panzuto in
Google Scholar
PubMed
Search for other papers by Silvia Nasoni in
Google Scholar
PubMed
Search for other papers by Massimo Falconi in
Google Scholar
PubMed
Search for other papers by Vito Domenico Corleto in
Google Scholar
PubMed
Search for other papers by Gabriele Capurso in
Google Scholar
PubMed
Search for other papers by Sara Cassetta in
Google Scholar
PubMed
Search for other papers by Michela Di Fonzo in
Google Scholar
PubMed
Search for other papers by Valentina Tornatore in
Google Scholar
PubMed
Search for other papers by Massimo Milione in
Google Scholar
PubMed
Search for other papers by Stefano Angeletti in
Google Scholar
PubMed
Search for other papers by Maria Sofia Cattaruzza in
Google Scholar
PubMed
Search for other papers by Vincenzo Ziparo in
Google Scholar
PubMed
Search for other papers by Cesare Bordi in
Google Scholar
PubMed
Search for other papers by Paolo Pederzoli in
Google Scholar
PubMed
Search for other papers by Gianfranco Delle Fave in
Google Scholar
PubMed
Introduction Gastro-entero-pancreatic endocrine tumors (GEP ETs) are rare neoplasms, with 1–4 cases per 100 000 people per year ( Quaedvlieg et al. 2001 , Modlin et al. 2003 , Lepage et al. 2004 , Taal & Visser 2004
Search for other papers by Yasuhiko Nagano in
Google Scholar
PubMed
Search for other papers by Do Ha Kim in
Google Scholar
PubMed
Search for other papers by Li Zhang in
Google Scholar
PubMed
Search for other papers by Jill A White in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
Search for other papers by Stanley R Hamilton in
Google Scholar
PubMed
Search for other papers by Asif Rashid in
Google Scholar
PubMed
Introduction Pancreatic endocrine tumors (PETs) are uncommon, mostly well-differentiated and indolent neuroendocrine neoplasms, with an age-adjusted annual incidence of <1 per 100 000 ( Buchanan et al. 1986 ). The molecular